NAV-005

N/A

Report date: 2024/06/27 11:03:56

Base Information

Drug NameNAV-005
Drug Alias NameNAV-005
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsMucin-16 inhibitors
TargetsMucin-16
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNavrogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesNavrogen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A